2026 China Healthcare Decision-Makers Conference (CHDC)
Every step forward in corporate competitiveness begins with the judgment and leadership of decision-makers. From target selection and technology platform choices to product portfolio decisions, clinical development strategies, BD transactions, market access, and the transformative impact of AI on the entire healthcare ecosystem — decisions made across these critical scenarios shape the future trajectory of companies and may redefine the competitive landscape of entire therapeutic areas. Whether navigating a rapidly expanding market or competing in an increasingly challenging environment, the quality of strategic decision-making has become a defining factor separating companies that thrive from those that struggle.
The China Healthcare Decision-Makers Conference (CHDC) is positioned as “a platform for strategic dialogue, knowledge exchange, and collaboration among healthcare decision-makers.” Focusing on key decision-making scenarios across the entire biopharmaceutical value chain and throughout the lifecycle of innovative medicines, CHDC brings together high-quality keynote presentations, expert discussions, and strategic dialogues to help industry leaders clarify priorities, identify emerging trends, build consensus, and ultimately improve decision quality — driving business success and promoting sustainable growth of the healthcare industry.
At the 2026 China Healthcare Decision-Makers Conference, participants will experience immersive discussions based on real-world strategic challenges faced by pharmaceutical companies, alongside forward-looking conversations exploring how AI is reshaping the future of the industry. We believe that attendees will not only gain actionable decision-making frameworks and strategic insights, but also discover potential partners aligned with their business objectives. Ultimately, CHDC aims to transform industry dialogue into tangible opportunities for collaboration and business advancement. We look forward to welcoming you back to Beijing.
Conference Overview
Organizers: PharmCube
Supporting Organizations: Etown Bio
Date: October 27–28, 2026
Venue: Beijing Yizhuang · Grand Skylight International Hotel, Beijing, China
Expected Attendance: 1,000+ participants
Attendee Profile:
- Government regulators and biomedical industrial park leaders (Gain insights into policy direction and industry trends)
- C-level executives from pharmaceutical companies (Shape corporate strategy and define future direction)
- Leaders in strategy, portfolio planning, clinical development, market access, and commercialization (Driving critical business decisions)
- BD executives and investors (Identify promising assets and partnership opportunities)
- Market access and commercial strategy leaders (Develop future market positioning and strategic plans)
